ClinicalTrials.gg
Not yet recruitingNCT07889050CRYO-IRISUpdated Oct 22, 2026

Effect of Intracanal Cryotherapy on Pain, Anxiety, and Salivary Irisin After Root Canal Treatment

An interventional study of Intracanal Cryotherapy and Standard Room-Temperature Irrigation in Postoperative Pain After Endodontic Treatment, Dental Anxiety and Root Canal Treatment, sponsored by Alanya Alaaddin Keykubat University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Alanya Alaaddin Keykubat University · Not applicable, Interventional, and Supportive care

Updated Oct 22, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Some people feel pain after a root canal treatment. This study will test whether intracanal cryotherapy, a final rinse of the tooth with cold sterile saline, can reduce this pain compared with a room-temperature rinse.

Previous studies have suggested that intracanal cryotherapy may reduce pain after root canal treatment. In this study, we will examine its effect in a defined group of patients and explore how it works. We will measure the level of irisin, a substance with reported anti-inflammatory properties, in saliva to see whether cryotherapy changes it. We will also look at whether a person's tendency to worry about pain (pain catastrophizing) changes the effect of cryotherapy on pain, and whether dental anxiety is related to pain after treatment.

Adults aged 18 to 65 who need root canal treatment on a single-rooted lower premolar tooth will receive standard single-visit treatment. By chance, 100 participants will be placed in a cold-saline group or a room-temperature-saline group. Thirty healthy volunteers will give one saliva sample for comparison. Participants will complete questionnaires before treatment, rate their pain over the 7 days after treatment, and give saliva samples for irisin measurement.

The main questions this study aims to answer are:

Does intracanal cryotherapy lower pain after root canal treatment? Does it change salivary irisin levels? Does pain catastrophizing change the effect of cryotherapy? Is dental anxiety related to pain after treatment?

Read the detailed description

Postoperative pain after root canal treatment remains a common clinical challenge, even when the procedure is performed correctly. Intracanal cryotherapy, a final irrigation of the root canal with cooled sterile saline, has been proposed to reduce postoperative inflammation and pain by slowing local tissue metabolism and limiting the release of inflammatory mediators. Previous studies have reported a pain-reducing effect, but the biological mechanism is not fully understood.

Irisin is a myosine with reported anti-inflammatory properties, and, to our knowledge, its measurement in saliva in the context of endodontic pain has not been previously investigated. Pain catastrophizing has been associated with higher postoperative pain in previous studies, but it remains unclear whether it influences the effect of cryotherapy on pain. This study addresses cryotherapy, salivary irisin, and pain catastrophizing together within a biopsychosocial pain framework.

This is a prospective, randomized, controlled clinical trial. Adults with asymptomatic apical periodontitis in single-rooted, single-canal mandibular premolar teeth will receive single-visit root canal treatment from a single operator and will be randomly assigned to one of two groups. The intervention group will receive final irrigation with cooled saline, and the control group will receive final irrigation with room-temperature saline, using the same irrigation device. A group of healthy individuals will provide a single saliva sample for reference values.

Postoperative pain will be assessed with the Visual Analog Scale. Pain catastrophizing and dental anxiety will be assessed with validated questionnaires before treatment. Saliva samples will be collected before and after treatment to measure irisin levels.

The findings may clarify whether cryotherapy is associated with reduced postoperative pain and a change in a salivary inflammatory biomarker, whether pain catastrophizing influences the effect of cryotherapy on postoperative pain, and whether salivary irisin can serve as a non-invasive biomarker in endodontics.

02

Conditions studied

  • Postoperative Pain After Endodontic Treatment
  • Dental Anxiety
  • Root Canal Treatment

Browse trials for

Keywords

  • Root canal treatment
  • Intracanal cryotherapy
  • Postoperative pain
  • Pain catastrophizing
  • Dental anxiety
  • Salivary irisin
  • Endodontics
  • Single-visit root canal treatment
03

In context

Pain, Postoperative

5,224 studies on the registry are indexed under Pain, Postoperative; 1,154 are open to participants now.

This study's planned enrollment of 130 is above the median of 75 across 4,457 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Alanya Alaaddin Keykubat University is the lead sponsor of 49 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 to 65 years
  • Single-rooted, single-canal mandibular premolar teeth with no previous root -canal treatment
  • Asymptomatic apical periodontitis (Periapical Index score ≥ 3)
  • Systemically healthy (ASA I-II)
  • Signed informed consent form
  • Able to be contacted and attend follow-up appointments
  • Able to maintain a pain diary
  • No use of anti-inflammatory medication within the past 3 months

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or breastfeeding
  • Systemic diseases (diabetes mellitus, cardiovascular disease, renal or hepatic insufficiency)
  • Use of immunosuppressive therapy
  • Use of corticosteroids or NSAIDs within the past 3 months
  • Use of antibiotics within the past 1 month
  • Presence of periapical abscess or sinus tract
  • Vertical root fracture
  • Root perforation
  • External or internal root resorption
  • Canal obstruction in the apical third
  • Periodontal disease (presence of pockets deeper than 3 mm)
  • Excessive dental hypersensitivity
  • Bruxism
  • Occlusal trauma
  • Mental or psychiatric disorder
  • Neurological disease affecting pain perception
  • Allergy to paracetamol
  • Refusal to participate in the study
  • Body mass index above 35 kg/m²
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
130 participants (estimated)

Study arms

  • Experimental
    Intracanal Cryotherapy

    Participants undergoing single-visit root canal treatment will receive intracanal cryotherapy using a cold irrigant delivered through a closed-system irrigation device (EndoVac) after completion of canal instrumentation and prior to obturation.

    Procedure: Intracanal Cryotherapy

  • Active comparator
    Control (Room-Temperature Irrigation)

    Participants undergoing single-visit root canal treatment will receive standard irrigation using the same closed-system irrigation device (EndoVac) with irrigant at room temperature, following the same canal instrumentation protocol as the intervention group.

    Procedure: Standard Room-Temperature Irrigation

  • No intervention
    Healthy Reference Group

    Saliva samples will be collected from healthy participants without an indication for root canal treatment, solely for the purpose of establishing normative salivary irisin reference values. These participants will not be randomized, will not undergo root canal treatment, and will not receive any study intervention.

Interventions

  • ProcedureIntracanal Cryotherapy

    Following completion of the standard EndoVac irrigation protocol, a group-specific final irrigation step will be performed. Sterile saline solution, refrigerated at +2°C and further cooled to 2.5°C in an ice-water bath, with temperature verified using a digital thermometer, will be delivered using the EndoVac system. A total of 20 mL of cooled saline will be applied over 5 minutes, with the micro-cannula positioned at working length to ensure effective delivery of the cold irrigant to the apical region via negative pressure.

  • ProcedureStandard Room-Temperature Irrigation

    Following completion of the standard EndoVac irrigation protocol, a group-specific final irrigation step will be performed. Sterile saline solution prepared at room temperature (20-22°C) will be delivered using the EndoVac system, following the same protocol as the intervention group. A total of 20 mL of room-temperature saline will be applied over 5 minutes, using the same technique and duration.

06

What researchers measure

Primary outcomes

  1. Postoperative Pain as Assessed by Visual Analog Scale (VAS)

    Postoperative pain will be self-assessed by participants using a 100 mm Visual Analog Scale (VAS), consisting of a horizontal line where participants mark the point that best represents their level of pain intensity. The left end (0 mm) indicates "no pain" and the right end (100 mm) indicates "the most severe pain I have ever felt in my life." Scores are measured in millimeters, with higher scores indicating greater pain intensity. Participants will record their VAS score in a standardized pain diary at each assessment time point, along with any rescue analgesic (paracetamol 500 mg) use, including time and dose, and any adverse events or unexpected occurrences. A blinded researcher, unaware of group allocation, will telephone participants at each designated time point to record pain scores and remind them to complete the diary.

    Time frame: 24 hours after root canal treatment

Secondary outcomes

  1. Postoperative Pain as Assessed by Visual Analog Scale (VAS) at 6 Hours

    Postoperative pain will be self-assessed using a 100 mm Visual Analog Scale (VAS). The left end (0 mm) indicates "no pain" and the right end (100 mm) indicates "the most severe pain I have ever felt in my life." Higher scores indicate greater pain intensity.

    Time frame: 6 hours after root canal treatment

  2. Postoperative Pain as Assessed by Visual Analog Scale (VAS) at 12 Hours

    Postoperative pain will be self-assessed using a 100 mm Visual Analog Scale (VAS). The left end (0 mm) indicates "no pain" and the right end (100 mm) indicates "the most severe pain I have ever felt in my life." Higher scores indicate greater pain intensity.

    Time frame: 12 hours after root canal treatment

  3. Postoperative Pain as Assessed by Visual Analog Scale (VAS) at 48 Hours

    Postoperative pain will be self-assessed using a 100 mm Visual Analog Scale (VAS). The left end (0 mm) indicates "no pain" and the right end (100 mm) indicates "the most severe pain I have ever felt in my life." Higher scores indicate greater pain intensity.

    Time frame: 48 hours after root canal treatment

  4. Postoperative Pain as Assessed by Visual Analog Scale (VAS) at 72 Hours

    Postoperative pain will be self-assessed using a 100 mm Visual Analog Scale (VAS). The left end (0 mm) indicates "no pain" and the right end (100 mm) indicates "the most severe pain I have ever felt in my life." Higher scores indicate greater pain intensity.

    Time frame: 72 hours after root canal treatment

  5. Postoperative Pain as Assessed by Visual Analog Scale (VAS) at 7 Days

    Postoperative pain will be self-assessed using a 100 mm Visual Analog Scale (VAS). The left end (0 mm) indicates "no pain" and the right end (100 mm) indicates "the most severe pain I have ever felt in my life." Higher scores indicate greater pain intensity.

    Time frame: 7 days (168 hours) after root canal treatment

  6. Pain Catastrophizing as Assessed by Pain Catastrophizing Scale (PCS)

    Pain catastrophizing will be assessed using the Pain Catastrophizing Scale (PCS), a validated self-report questionnaire measuring the tendency to exaggerate the threat value of pain. Higher scores indicate greater pain catastrophizing.

    Time frame: Baseline, prior to root canal treatment

  7. Dental Anxiety as Assessed by Modified Dental Anxiety Scale (MDAS)

    Dental anxiety will be assessed using the Modified Dental Anxiety Scale (MDAS), a validated self-report questionnaire measuring anxiety related to dental treatment. Higher scores indicate greater dental anxiety.

    Time frame: Baseline, prior to root canal treatment

  8. Salivary Irisin Level at Baseline

    Salivary irisin concentration will be measured in unstimulated saliva samples collected using the passive drooling method, analyzed by enzyme-linked immunosorbent assay (ELISA).

    Time frame: Baseline, prior to root canal treatment

  9. Salivary Irisin Level at 24 Hours

    Salivary irisin concentration will be measured in unstimulated saliva samples collected using the passive drooling method, analyzed by enzyme-linked immunosorbent assay (ELISA).

    Time frame: 24 hours after root canal treatment

  10. Salivary Irisin Level at 72 Hours

    Salivary irisin concentration will be measured in unstimulated saliva samples collected using the passive drooling method, analyzed by enzyme-linked immunosorbent assay (ELISA).

    Time frame: 72 hours after root canal treatment

  11. Salivary Irisin Level in Healthy Reference Group

    Salivary irisin concentration will be measured in a single unstimulated saliva sample collected from healthy participants without an indication for root canal treatment, using the passive drooling method and analyzed by enzyme-linked immunosorbent assay (ELISA), to establish normative reference values.

    Time frame: At the time of saliva sample collection, single time point

07

Study locations

1 site
  • Alanya Alaaddin Keykubat University, Faculty of Dentistry
    Antalya, Antalya 07400, Turkey (Türkiye)
08

References and documents

Publications

  • Salim FS, Saliem SS. Irisin, a promising adipomyokine, shows low levels in relation to periodontal diseases, unlike visfatin and IL-6 (case-control study). Front Oral Health. 2025 Nov 6;6:1614433. doi: 10.3389/froh.2025.1614433. eCollection 2025. PubMed 41280712 ↗
  • Gastmann AH, Xavier SR, Pilownic KJ, Romano AR, Gomes FA, Goettems ML, Morgental RD, Pappen FG. Pain, anxiety, and catastrophizing among pregnant women with dental pain, undergoing root canal treatment. Braz Oral Res. 2024 Jun 24;38:e054. doi: 10.1590/1807-3107bor-2024.vol38.0054. eCollection 2024. PubMed 38922214 ↗
  • Rahman MM, Hwang SM, Go EJ, Kim YH, Park CK. Irisin alleviates CFA-induced inflammatory pain by modulating macrophage polarization and spinal glial cell activation. Biomed Pharmacother. 2024 Sep;178:117157. doi: 10.1016/j.biopha.2024.117157. Epub 2024 Jul 22. PubMed 39042964 ↗
  • Almohaimede A, Al-Madi E. Is Intracanal Cryotherapy Effective in Reducing Postoperative Endodontic Pain? An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials. Int J Environ Res Public Health. 2021 Nov 9;18(22):11750. doi: 10.3390/ijerph182211750. PubMed 34831517 ↗

Individual participant data

Plan to share: No — There is no plan to share individual participant data, as no data-sharing repository or mechanism has been established for this study. Only aggregate results will be published.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07889050
Lead sponsor
Alanya Alaaddin Keykubat University
Responsible party
Hatice BÜYÜKÖZER ÖZKAN (Principal Investigator, Alanya Alaaddin Keykubat University) — Principal investigator
First posted
Oct 22, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Nov 15, 2027 (estimated)
Completion
Feb 15, 2028 (estimated)
Last update
Oct 22, 2026

Study contacts

MELİKE FİLİZ, DDS
Contact
melike.filiz@alanya.edu.tr
+90 543 376 8005
Hatice Buyukozer Ozkan, PhD
Contact
hatice.ozkan@alanya.edu.tr
+90 530 971 02 52
Hatice Buyukozer Ozkan, PhD
principal investigator · Alanya Alaaddin Keykubat University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion